News Focus
News Focus
Followers 29
Posts 7857
Boards Moderated 0
Alias Born 03/16/2017

Re: Rifleshaft post# 20860

Friday, 08/24/2018 12:21:01 PM

Friday, August 24, 2018 12:21:01 PM

Post# of 84815
Excellent commentary and I didnt even think of the post approval issues with pricing!

I will re-iterate my idea that CVSI, after patent approval, offer a significant % of the rights to the patent (however such deals are structured) to a big pharma co in exchange for that company to pay all expenses for the trials. Even if we give that company 50%(or more) of the profits if approved by FDA we lose nothing if the drug isnt successfull in clinical trials and we reap millions in net profits of approved and successful.

I hope they go this route with their pharma side.

Agree 100% on the CBD direct to consumer side.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News